PharmacovigilanceOfficial

AIFA: Italy's public pharmaceutical spending hits €13.42bn in first half of 2026

🇮🇹 AIFA · Thu 19 Nov 2026

AIFA's monitoring report puts January–June 2026 public drug spending at 19.07% of the provisional national health fund figure communicated by the Ministry of Health.

Italy's medicines agency AIFA has published its monitoring report on pharmaceutical expenditure for January to June 2026. Total public spending, covering convenzionata (retail reimbursed prescriptions), direct purchases and oxygen, came to €13,417.6 million.

Subscribe to keep reading

$4.99 / month

  • Every article, analysis and opinion piece on VigiEye and CompePharma
  • One subscription for both sites, cancel any time
Continue with Google
or
You'll be signed in straight away; we also email you a link to confirm your address. Reading every article takes a $4.99/month subscription (secure checkout by Stripe), billed monthly until you cancel; access starts at once, so the 14-day withdrawal right ends when it does. See our terms and privacy policy.

Official source: AIFA ↗

Article written by VigiEye from the official source (AIFA). AI-assisted; check the source before acting.